Clinical Trials Logo

Clinical Trial Summary

Pregnancy is associated with a increased risk of developing blood clots. There is nearly a 5 times greater risk of developing a blood clot in pregnancy. Lovenox is a medication that helps to prevent the body from developing clots. It is safe to use in pregnancy. Previous studies have demonstrated that despite recommendation of Lovenox, to prevent blood clots, the majority of patient's (70 to 90%) did not receive adequate levels of Lovenox at times throughout the day, which likely increases the risk of developing clots. The increase in blood volume and increase in kidney function that occurs in pregnancy may contribute to the inadequate levels. Currently the recommendation for pregnant and nonpregnant patients requiring Lovenox, is to calculate the daily dose of Lovenox and split the dose, giving half in the morning and the other half in the evening. This research study proposes that due to changes in the body during pregnancy that the daily Lovenox dosing be split into three times a day to achieve more consistent levels of Lovenox than twice a day in pregnant women.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04861103
Study type Interventional
Source University of California, Irvine
Contact Lizette Spears
Phone 714.456.5694
Email [email protected]
Status Recruiting
Phase Phase 4
Start date October 1, 2020
Completion date July 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT03651843 - Perception of Risks Into Work During Pregnancy Among Post-partum Women in the Lille Metropolis
Not yet recruiting NCT03985618 - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity N/A
Completed NCT02008097 - Clinical Benefits of B-Flow Ultrasound N/A
Completed NCT03413631 - A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women N/A
Active, not recruiting NCT03334149 - Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension N/A
Completed NCT03646487 - A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Black Women N/A
Recruiting NCT04230967 - Ambulation for Latency During Expectant Management of PPROM N/A
Recruiting NCT03975894 - TAPS2 Transfusion Antenatally in Pregnant Women With SCD Phase 2
Not yet recruiting NCT04542148 - Glycemic Control After Antenatal Corticosteroids in Women With Pregestational Diabetes Phase 2
Completed NCT03467503 - Healthy Diet for Healthy Moms and Babies N/A
Completed NCT03737279 - Daily Meditation Program in Women Admitted to the Antepartum Unit N/A
Recruiting NCT04599075 - Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus Phase 4
Recruiting NCT03833245 - Optimizing Pregnancy and Treatment Interventions for Moms 2.0 N/A
Recruiting NCT03979196 - Inpatient vs Outpatient Management of Short Cervix N/A
Completed NCT02881073 - Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia N/A
Recruiting NCT03495895 - The Effectiveness of MInding the Baby in a Danish Community Sample N/A
Active, not recruiting NCT04291040 - Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies N/A
Recruiting NCT04571190 - An Adapted Mindfulness-based Stress Reduction Program for High-risk Pregnancies N/A
Not yet recruiting NCT04693572 - Anesthetic Considerations for Repeat Cesarean Section - a Prospective Study
Recruiting NCT04617405 - Hormonal and Inflammatory Changes During Pregnancy in Women With Glucose Metabolic Disorders.